Compounds > thromboxane-b2

thromboxane-b2 and Tuberculosis--Pulmonary

thromboxane-b2 has been researched along with Tuberculosis--Pulmonary* in 1 studies

Other Studies

1 other study(ies) available for thromboxane-b2 and Tuberculosis--Pulmonary

ArticleYear
The novel compound MP407 inhibits platelet aggregation through cyclic AMP-dependent processes.
    European journal of pharmacology, 2017, Nov-15, Volume: 815

    Topics: Adenosine Diphosphate; Animals; Benzyl Compounds; Biological Transport; Calcium; Cell Adhesion Molecules; Cyclic AMP; Glycogen Synthase Kinase 3 beta; Indoles; Mice; Microfilament Proteins; Phosphoproteins; Phosphorylation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Thromboxane B2; Tuberculosis, Pulmonary

2017